Acknowledgement
Supported by : National Natural Scientific Fund of China
References
- Calin GA, Sevignani C, Dumitru CD (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA, 101, 2999-3005. https://doi.org/10.1073/pnas.0307323101
- Cui W, Zhang S, Shan C, Zhou L, Zhou Z (2013). microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. FEBS J, 280, 3962-74. https://doi.org/10.1111/febs.12398
- Dong Y, Zhao J, Wu CW, et al (2013). Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res, 11, 1051-60. https://doi.org/10.1158/1541-7786.MCR-13-0061
- Gong Y, Ren J, Liu K, Tang LM (2015). Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1. World J Gastroenterol, 21, 2949-58. https://doi.org/10.3748/wjg.v21.i10.2949
- Guo J, Xia B, Meng F, Lou G (2014). miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. Tumour Biol, 35, 1557-64. https://doi.org/10.1007/s13277-013-1215-z
- Kinoshita T, Nohata N, Watanabe-Takano H, et al (2012). Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma. Int J Oncol, 40, 1770-8.
- Lai C, Chen Z, Li R (2015). MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1. Mol Med Rep, 12, 1473-8. https://doi.org/10.3892/mmr.2015.3545
- Lin Y, Ueda J, Kikuchi S, et al (2011). Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol, 17, 4421-8. https://doi.org/10.3748/wjg.v17.i39.4421
- Moriya Y, Nohata N, Kinoshita T, et al (2012). Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J Hum Genet, 57, 38-45 . https://doi.org/10.1038/jhg.2011.126
- Nohata N, Hanazawa T, Enokida H, Seki N (2012). microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget, 3, 9-21. https://doi.org/10.18632/oncotarget.424
- Qiu T, Zhou X, Wang J, et al (2014). MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett, 588, 1168-77. https://doi.org/10.1016/j.febslet.2014.02.054
- Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Tucci A, Bisceglia M, Rugge M, et al (2007). Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc, 66, 881-90. https://doi.org/10.1016/j.gie.2007.03.1052
- Wang LK, Hsiao TH, Hong TM, et al (2014). MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS One, 9, 96765. https://doi.org/10.1371/journal.pone.0096765
- Wu WK, Lee CW, Cho CH, et al (2010). MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene, 29, 5761-71. https://doi.org/10.1038/onc.2010.352
- Yamasaki T, Yoshino H, Enokida H, et al (2012). Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. Int J Oncol, 40, 1821-30.
- Zhang X, Cui L, Ye G, et al (2012). Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumour Biol, 33, 2349-55. https://doi.org/10.1007/s13277-012-0497-x